Stocks That Hit 52-Week Highs On Friday
During Friday's morning session, 235 stocks hit new 52-week highs.
46 Stocks Moving In Friday’s Mid-Day Session
Gainers
Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share.
Mid-Day Market Update: Markets Mixed; Novan Shares Spike Higher
Midway through trading Friday, the Dow traded down 0.07% to 34,442.46 while the NASDAQ rose 0.09% to 14,033.42. The S&P also rose, gaining 0.01% to 4,239.73.
A Technical Look At Novan’s Stock Amid 80% Spike
Novan Inc. (NASDAQ: NOVN) shares are trading higher Friday after the company reported that B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved significance for the primary endpoint with no adverse events.
Why Novan Shares Are Surging Today
Novan Inc (NASDAQ: NOVN) shares are trading higher by 59% at $14.37 Friday morning after the company reported the B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved statistical significance for the primary endpoint and no serious adverse events were reported.
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 10)
Novan’s Stock Surges As SB206 Can Potentially Shorten Duration Of Contagious Skin Disease
Novan Inc (NASDAQ:NOVN) has announced positive topline efficacy and safety results from the B-SIMPLE4 Phase 3 trial evaluating SB206, a topical…
Novan Reports Topline Results From Pivotal Phase 3 Trial Of SB206 In Patients With Molluscum Contagiosum: Achieves Statistical Significance, No Serious Adverse Events Reported
– B-SIMPLE4 achieves statistical significance for the primary endpoint with p-value less than 0.0001 –
– No serious adverse events related to treatment with SB206 –
– Novan intends to